Byrnes Michael 4
4 · eFFECTOR Therapeutics, Inc. · Filed Nov 16, 2022
Insider Transaction Report
Form 4
Byrnes Michael
Chief Financial Officer
Transactions
- Award
Common Stock
2022-11-15$0.47/sh+4,651$2,179→ 33,884 total
Footnotes (1)
- [F1]These shares were acquired under the eFFECTOR Therapeutics, Inc. 2021 Employee Stock Purchase Plan.